The Traverso Lab developed a system that uses machine learning to accelerate the design of more efficient lipid nanoparticles (LNPs) for delivery of RNA therapies. In a Nature Nanoparticles study, the researchers used the platform to identify effective LNP formulations for various cell types, including cells derived from colorectal cancer. This research was funded in part by the GO Nano Marble Center at the Koch Institute.